(State or other jurisdiction of incorporation or organization) | (Commission File Number) | (I.R.S. Employer Identification Number) |
Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||
Lexicon Pharmaceuticals, Inc. | ||||||||
Date: August 2, 2021 | By: | /s/ Brian T. Crum | ||||||
Brian T. Crum | ||||||||
Vice President and General Counsel |
Cover |
Jul. 28, 2021 |
---|---|
Cover [Abstract] | |
Document Type | 8-K |
Document Period End Date | Jul. 28, 2021 |
Entity Registrant Name | Lexicon Pharmaceuticals, Inc. |
Entity Incorporation, State or Country Code | DE |
Entity File Number | 000-30111 |
Entity Tax Identification Number | 76-0474169 |
Entity Address, Address Line One | 2445 Technology Forest Blvd., |
Entity Address, City or Town | The Woodlands |
Entity Address, State or Province | TX |
Entity Address, Postal Zip Code | 77381 |
City Area Code | 281 |
Local Phone Number | 863-3000 |
Title of 12(b) Security | Common Stock, par value $0.001 |
Trading Symbol | LXRX |
Security Exchange Name | NASDAQ |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |
Entity Emerging Growth Company | false |
Entity Central Index Key | 0001062822 |
Amendment Flag | false |
Entity Address, Address Line Two | 11th Floor |
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
FM8[P[H;N*)\5<^9,\W+UQ2#&5 44*!\*
M@(5U26#, 842Z